UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 29, 2016 4:30 P.M.
Form: S-3
CIK: 0001504167
Company Name: BioPharmX Corp
File Number: 333-213635